← All trials
NCT02582203
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2012
- Primary completion
- May 1, 2016
- Completion date
- May 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 174
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Wayne State UniversityLead sponsor
- Wayne State UniversityOverall official - principal investigator
- Wayne State UniversityReponsible party - principal investigator
- St. John Providence Health SystemCollaborator
- Forest LaboratoriesCollaborator
- Henry Ford Health SystemCollaborator
- Wayne State UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.